Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Samson

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
RMD Open|February 23, 2026
Orbital MRI for diagnosing giant cell arteritis in cases of anterior ischaemic optic neuropathyGuillaume Brenac, Angélique Bernard, Brivael Lemogne, et al.
Rheumatology (Oxford, England)|July 13, 2024
Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world studyCharlotte Gabilan, Julie Belliere, Olivier Moranne, et al.
Autoimmunity Reviews|June 10, 2019
Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: A case study and literature reviewJulien Rohmer, Matthieu Groh, Maxime Samson, et al.
Arthritis Research & Therapy|May 20, 2021
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritisHubert de Boysson, Maelle Le Besnerais, Félix Blaison, et al.
Biomed Research International|October 23, 2015
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1Malika Trad, Alexandrine Gautheron, Jennifer Fraszczak, et al.
Journal of Clinical Medicine|July 8, 2020
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune ThrombocytopeniaThomas Rogier, Maxime Samson, Guillaume Mourey, et al.
Annals of the Rheumatic Diseases|February 13, 2026
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritisJean-Paul Makhzoum, Maria C Cid, Maxime Samson, et al.
European Journal of Internal Medicine|June 11, 2022
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patientsMaxime Samson, Barbara Nicolas, Marion Ciudad, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2025
Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell InflammationDamien Leleu, Thomas Pilot, Léa Mangin, et al.
Rheumatology (Oxford, England)|August 17, 2023
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosusThomas Thibault, Abdessamad Rajillah, Abderrahmane Bourredjem, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
RMD Open|February 23, 2026
Orbital MRI for diagnosing giant cell arteritis in cases of anterior ischaemic optic neuropathyGuillaume Brenac, Angélique Bernard, Brivael Lemogne, et al.
Rheumatology (Oxford, England)|July 13, 2024
Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world studyCharlotte Gabilan, Julie Belliere, Olivier Moranne, et al.
Autoimmunity Reviews|June 10, 2019
Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: A case study and literature reviewJulien Rohmer, Matthieu Groh, Maxime Samson, et al.
Arthritis Research & Therapy|May 20, 2021
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritisHubert de Boysson, Maelle Le Besnerais, Félix Blaison, et al.
Biomed Research International|October 23, 2015
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1Malika Trad, Alexandrine Gautheron, Jennifer Fraszczak, et al.
Journal of Clinical Medicine|July 8, 2020
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune ThrombocytopeniaThomas Rogier, Maxime Samson, Guillaume Mourey, et al.
Annals of the Rheumatic Diseases|February 13, 2026
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritisJean-Paul Makhzoum, Maria C Cid, Maxime Samson, et al.
European Journal of Internal Medicine|June 11, 2022
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patientsMaxime Samson, Barbara Nicolas, Marion Ciudad, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2025
Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell InflammationDamien Leleu, Thomas Pilot, Léa Mangin, et al.
Rheumatology (Oxford, England)|August 17, 2023
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosusThomas Thibault, Abdessamad Rajillah, Abderrahmane Bourredjem, et al.
Pageof 19